US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

28.27

-1.4700-4.94%

Post-market: 28.270.00000.00%19:30 EDT

Volume:268.48K

Turnover:7.70M

Market Cap:728.77M

PE:-0.20

High:31.13

Open:29.56

Low:27.66

Close:29.74

52wk High:42.14

52wk Low:7.45

Shares:25.78M

Float Shares:811.70K

Volume Ratio:0.77

T/O Rate:33.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-141.6499

EPS(LYR):-16.7239

ROE:-195.26%

ROA:-20.79%

PB:4.21

PE(LYR):-1.69

Loading ...

Overview Company News Filings

Faeth Therapeutics Adds Cancer Expert to Board

Faeth Therapeutics Names Karen Vousden to Board

Faeth Therapeutics Appoints Karen Vousden, Ph.d., to Board of Directors

THOMSON REUTERS

Guggenheim Initiates Faeth Therapeutics at Buy With $70 Price Target

MT Newswires Live

Faeth Therapeutics Director Karen H. Vousden Files Initial Beneficial Ownership Statement

Faeth Therapeutics initiated with a Buy at Guggenheim

Faeth Therapeutics Initiated at Buy by LUCID Capital Markets

Faeth Therapeutics assumed with a Buy at Lucid Capital

Wall Street Analysts Are Bullish on Top Healthcare Picks

Faeth Therapeutics Initiated at Buy by TD Cowen

TD Cowen Initiates Coverage on Faeth Therapeutics With Buy Rating

MT Newswires Live

Faeth Therapeutics initiated with a Buy at TD Cowen

Faeth Therapeutics to Host Virtual KOL Event on Endometrial Cancer Multi-Nodal Inhibition

Faeth Therapeutics Outlines Piktor PI3K-alpha/mTOR Inhibitor Regimen in Corporate Presentation

Faeth Therapeutics to Present at Upcoming Investor Healthcare Conferences

Faeth Therapeutics Grants 94,000 Inducement Stock Options at USD 34.52 Per Share

Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Needham Initiates Faeth Therapeutics at Buy With $56 Price Target

MT Newswires Live

Faeth Therapeutics Initiated at Buy by Needham

Faeth Therapeutics Initiated at Buy on Oral Multi‑Node PI3K/AKT/mTOR Strategy; Analyst Sets $56 Price Target

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/FTH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":28.27,"timestamp":1790884800000,"preClose":29.74,"halted":0,"volume":268483,"hourTrading":{"tag":"盘后","latestPrice":28.27,"preClose":28.27,"latestTime":"19:30 EDT","volume":278,"amount":7860.18,"timestamp":1790897404632,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04942837928715531,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"Not Yet Opened","change":-1.47,"latestTime":"10-01 16:00:00 EDT","open":29.56,"high":31.13,"low":27.66,"amount":7700866.744972001,"amplitude":0.116678,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-141.6499,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790928000000},"marketStatusCode":0,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":29.74,"preHourTrading":{"tag":"盘前","latestPrice":29.74,"preClose":29.74,"latestTime":"09:22 EDT","volume":25009,"amount":743767.6599999999,"timestamp":1790860929154,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":28.27,"preClose":28.27,"latestTime":"19:30 EDT","volume":278,"amount":7860.18,"timestamp":1790897404632,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.771795},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":0.771795,"shares":25778800,"dividePrice":0,"high":31.13,"amplitude":0.116678,"preClose":29.74,"low":27.66,"week52Low":7.45,"pbRate":"4.21","week52High":42.1431,"institutionHeld":0,"latestPrice":28.27,"eps":-141.6499,"divideRate":0,"volume":268483,"delay":0,"ttmEps":-141.6499,"open":29.56,"prevYearClose":10.67,"prevWeekClose":28,"prevMonthClose":29.74,"prevQuarterClose":29.74,"fiveDayClose":29.05,"twentyDayClose":39.12,"sixtyDayClose":28.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":14,"updateTime":1789531200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-09-30","current":-0.199577,"percent":0.690141,"low":-5.292894,"twenty":-4.561801,"median":-4.03542,"eighty":-3.433217,"high":-0.105707,"avg":-3.904193,"sd":1.07169,"marketCap":725340729},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-11","current":-5.154129,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"marketCap":1007776575},{"date":"2026-09-18","current":-4.642681,"twenty":-4.603777,"median":-4.03542,"eighty":-3.398343,"marketCap":907774130},{"date":"2026-09-25","current":-3.839165,"twenty":-4.572109,"median":-4.071058,"eighty":-3.426788,"marketCap":750664346},{"date":"2026-09-30","current":-3.709651,"twenty":-4.561801,"median":-4.03542,"eighty":-3.433217,"marketCap":725340729}],"updateTime":1790913636155},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668599758","title":"Faeth Therapeutics Adds Cancer Expert to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2668599758","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668599758?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:57","pubTimestamp":1789678624,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Faeth Therapeutics ( ($FTH) ). On September 11, 2026, Faeth Therapeutics, Inc. expanded its Board of Directors ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/faeth-therapeutics-adds-cancer-expert-to-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/faeth-therapeutics-adds-cancer-expert-to-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994206","title":"Faeth Therapeutics Names Karen Vousden to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994206","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994206?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:00","pubTimestamp":1789675228,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics names Karen Vousden to boardFaeth Therapeutics appointed Karen Vousden to its board, effective Sept. 11, 2026.Vousden has been a principal group leader at the Francis Crick Institut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL7Ps67b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668994208","title":"Faeth Therapeutics Appoints Karen Vousden, Ph.d., to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2668994208","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668994208?lang=en_us&edition=fundamental","pubTime":"2026-09-18 04:00","pubTimestamp":1789675200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nTUA6KKXBY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607607","title":"Guggenheim Initiates Faeth Therapeutics at Buy With $70 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607607","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607607?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:53","pubTimestamp":1789556001,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics (FTH) has an average rating of buy and mean price target of $56.67, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622649","title":"Faeth Therapeutics Director Karen H. Vousden Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622649","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622649?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:57","pubTimestamp":1789505864,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics director Karen H. Vousden files initial beneficial ownership statementFaeth Therapeutics director Karen H. Vousden reported 42,631 shares of common stock held directly as of Sept. 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDLHBX1g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667762423","title":"Faeth Therapeutics initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2667762423","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667762423?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:20","pubTimestamp":1789503654,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Brad Canino initiated coverage of Faeth Therapeutics (FTH) with a Buy rating and $70 price target Published first on TheFly – th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667766027","title":"Faeth Therapeutics Initiated at Buy by LUCID Capital Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2667766027","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667766027?lang=en_us&edition=fundamental","pubTime":"2026-09-15 01:36","pubTimestamp":1789407360,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667812662","title":"Faeth Therapeutics assumed with a Buy at Lucid Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667812662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667812662?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:55","pubTimestamp":1789397722,"startTime":"0","endTime":"0","summary":"Lucid Capital assumed coverage of Faeth Therapeutics (FTH) with a Buy rating and $59 price target The firm sees current share levels as offering an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-assumed-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-assumed-with-a-buy-at-lucid-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCDL","BK4596","BK4099","FTH","LCID","BK4551","BK4139","LCIZ","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667639921","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667639921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667639921?lang=en_us&edition=fundamental","pubTime":"2026-09-14 09:20","pubTimestamp":1789348809,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Faeth Therapeutics (FTH), 4D Molecular Therapeutics ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-337?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-337?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LU0029874061.USD","BK4588","LABU","BK4139","XLV","BK4585","FTH","BK4581","HCSG","BK4137","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666391925","title":"Faeth Therapeutics Initiated at Buy by TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666391925","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666391925?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:40","pubTimestamp":1788964800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TD","BK4207","BK4139","BK4127","BK4566","GSIB","FTH","BK4585","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666853814","title":"TD Cowen Initiates Coverage on Faeth Therapeutics With Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666853814","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666853814?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:09","pubTimestamp":1788955770,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics (FTH) has an average rating of buy and mean price target of $54.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FTH","TD","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666841025","title":"Faeth Therapeutics initiated with a Buy at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666841025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666841025?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948657,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Tara Bancroft initiated coverage of Faeth Therapeutics (FTH) with a Buy rating and no price target PIKTOR is validated by the rece...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-td-cowen-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","FTH","GSIB","BK4566","BK4207","TD","BK4585","BK4139","COWN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327985","title":"Faeth Therapeutics to Host Virtual KOL Event on Endometrial Cancer Multi-Nodal Inhibition","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327985?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:31","pubTimestamp":1788867096,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics to host virtual KOL event on endometrial cancer multi-nodal inhibitionFaeth Therapeutics will host a virtual key opinion leader event on Oct. 6, 2026 at 10:00 a.m. ET.Discussion to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLZWNqL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364470","title":"Faeth Therapeutics Outlines Piktor PI3K-alpha/mTOR Inhibitor Regimen in Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364470","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364470?lang=en_us&edition=fundamental","pubTime":"2026-09-06 19:48","pubTimestamp":1788695300,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics outlines PIKTOR PI3K-alpha/mTOR inhibitor regimen in corporate presentationFaeth outlined its oral PI3K/AKT/mTOR regimen PIKTOR, combining serabelisib with sapanisertib for multi-no","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nNDL25GkWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855144","title":"Faeth Therapeutics to Present at Upcoming Investor Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855144","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855144?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262228,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics to present at upcoming investor healthcare conferencesFaeth Therapeutics management will attend investor conferences in Boston, New York from Sept. 8-17, 2026.Schedule includes Well","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL5GXPjZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","BK4566","BK4585","LU0098860793.USD","LU0320765646.SGD","BK4559","LU1989772923.USD","LU1791807156.HKD","LU2089283258.USD","LU0006306889.USD","LU1244550494.USD","FTXO","BK4139","LU0170899867.USD","BK4534","LU0130102774.USD","IAI","BK4516","LU1244550577.SGD","LU1074936037.SGD","LU0203347892.USD","BK4581","LU1732800096.USD","LU1506573853.SGD","LU0314106906.USD","LU0162691827.USD","LU0314104364.USD","LU0128525689.USD","LU1720051017.SGD","LU0158827781.USD","LU0648001328.SGD","LU1162221912.USD","LU2360032135.SGD","FTH","TFNS","LU2125154778.USD","IE00B775SV38.USD","LU0225283273.USD","LU1988902786.USD","LU2111349929.HKD","IYF","LU0203345920.USD","LU1366192091.USD","KBWB","LU0130517989.USD","LU1064131342.USD","LU0477156953.USD","LU2133065610.SGD","LU0234570918.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662067997","title":"Faeth Therapeutics Grants 94,000 Inducement Stock Options at USD 34.52 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662067997","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662067997?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:30","pubTimestamp":1787916625,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics grants 94,000 inducement stock options at USD 34.52 per shareFaeth Therapeutics granted new-hire stock options covering 94,000 shares, effective Aug. 25, 2026, under its 2026 Induce","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL8csZQc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662601067","title":"Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662601067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662601067?lang=en_us&edition=fundamental","pubTime":"2026-08-28 19:30","pubTimestamp":1787916600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUABTC2MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661926459","title":"Needham Initiates Faeth Therapeutics at Buy With $56 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2661926459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661926459?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:23","pubTimestamp":1787307814,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics (FTH) has an average rating of buy and mean price target of $54.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661426261","title":"Faeth Therapeutics Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2661426261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661426261?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:04","pubTimestamp":1787306640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261199","title":"Faeth Therapeutics Initiated at Buy on Oral Multi‑Node PI3K/AKT/mTOR Strategy; Analyst Sets $56 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261199","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661261199?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:55","pubTimestamp":1787306119,"startTime":"0","endTime":"0","summary":"Gil Blum, an analyst from Needham, has initiated a new Buy rating on Faeth Therapeutics (FTH). Gil Blum has given his Buy rating due to a combinati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/faeth-therapeutics-initiated-at-buy-on-oral-multinode-pi3k-akt-mtor-strategy-analyst-sets-56-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/faeth-therapeutics-initiated-at-buy-on-oral-multinode-pi3k-akt-mtor-strategy-analyst-sets-56-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":92,"code":"91000000","status":"200"}]}}